Prognostic factors for survival in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic therapies: Overall results of a large experience.

被引：0
|
作者：
Procopio, G.
Verzoni, E.
Iacovelli, R.
Mattana, F.
Guadalupi, V.
Mariani, L.
Stagni, S.
Salvioni, R.
Buzzoni, R.
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Div Med Oncol, Rome, Italy
[3] Stat Unit Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic Factors and Overall Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Anti-angiogenic Therapies - Results of a Large Experience From a Single Institution
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Mattana, F.
    Guadalupi, V.
    Gelsomino, F.
    Stagni, S.
    Salvioni, R.
    Buzzoni, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S520 - S520
  • [2] Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies
    Denouel, Angeline
    Heutte, Natacha
    Escudier, Bernard
    Kurtz, Jean-Emmanuel
    Dos Santos, Melanie
    Longato, Nadine
    Desrues, Laurence
    Dauchy, Sarah
    Lange, Marie
    Sevin, Emmanuel
    Rieux, Chantal
    Clarisse, Benedicte
    Castel, Helene
    Noal, Sabien
    Joly, Florence
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 369 - +
  • [3] CLINICAL PROGNOSTIC FACTORS ASSOCIATED WITH OUTCOME IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED WITH ANTIANGIOGENIC AGENTS
    Bracarda, S.
    De Angelis, V.
    Caserta, C.
    Rossi, M.
    Hamzaj, A.
    Crino, L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 195 - 195
  • [4] OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) SEQUENTIALLY TREATED WITH DIFFERENT TARGETED THERAPIES (TTS): RESULTS FROM A LARGE COHORT OF PATIENTS
    Procopio, G.
    Verzoni, E.
    Testa, I.
    Iacovelli, R.
    Garanzini, E.
    De Braud, F. G. M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 272 - 273
  • [5] OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS' SEQUENTIALLY TREATED WITH TARGETED THERAPIES (TTS)
    Procopio, G.
    Verzoni, E.
    Testa, I.
    de Braud, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [6] Overall survival (OS) in metastatic renal cell carcinoma (mRCC) sequentially treated with different targeted therapies (TTs): Results from a large cohort of patients
    Procopio, Giuseppe
    Verzoni, Elena
    Iacovelli, Roberto
    Testa, Isabella
    Salvioni, Roberto
    Nicolai, Nicola
    Porcu, Luca
    De Braud, Filippo G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    G Procopio
    E Verzoni
    R Iacovelli
    D Biasoni
    I Testa
    L Porcu
    F De Braud
    [J]. British Journal of Cancer, 2012, 107 : 1227 - 1232
  • [8] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Biasoni, D.
    Testa, I.
    Porcu, L.
    De Braud, F.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (08) : 1227 - 1232
  • [9] Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Patil, S.
    Figlin, R. A.
    Hutson, T. E.
    Michaelson, M. D.
    Negrier, S.
    Kim, S. T.
    Huang, X.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Sequential Use of Targeted Therapies (TT) in Metastatic Renal Cell Cancer (mRCC): Overall Results of a Large Experience
    Verzoni, E.
    Buzzoni, R.
    Agustoni, F.
    Testa, I.
    Biondani, P.
    Catanzaro, M.
    Torelli, T.
    Procopio, G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S520 - S520
12345